CCL5 and atherosclerosis: Blockade of type-I IFN signaling in macrophages suppressed atherogenesis, while IFN-β treatment accelerated atherosclerosis through the induction of the chemokine CCL5 which leads to increased monocyte recruitment to plaques (34).